• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估 Tc-99m sestamibi 心肌灌注显像中接受分子乳腺成像的女性。

Evaluation of molecular breast imaging in women undergoing myocardial perfusion imaging with Tc-99m sestamibi.

机构信息

Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

J Womens Health (Larchmt). 2012 Jul;21(7):730-8. doi: 10.1089/jwh.2011.3267. Epub 2012 Mar 9.

DOI:10.1089/jwh.2011.3267
PMID:22404787
Abstract

BACKGROUND

Our objective was to explore the potential benefits of molecular breast imaging (MBI) as a screening technique in women undergoing stress myocardial perfusion studies.

METHODS

MBI was offered to women receiving Tc-99m sestamibi injection for myocardial perfusion stress testing. During the required waiting period after stress isotope injection, MBI was performed using a dedicated breast imaging gamma camera system. MBI examinations were interpreted by breast radiologists, with review of a recent mammogram in cases with positive MBI.

RESULTS

Of 322 women enrolled, 313 completed MBI, comprising 5 with known breast cancer, 2 with known high-risk benign breast lesions, and 306 who were asymptomatic for breast disease with a recent negative mammogram. Analysis was limited to the 306 patients with no known breast disease. MBI was positive in 22 of 306, giving a recall rate of 7.2% (95% confidence interval [CI] 4.8-10.6]. MBI detected 4 new cancers, resulting in a supplemental diagnostic yield of 13.1/1000 women screened (95% CI 5.1-33.2). The number of cancers diagnosed per abnormal MBI examinations (PPV(1)) was 18% (4 of 22) (95% CI 7.3-38.5), and the number diagnosed per MBI-prompted biopsies (PPV(3)) was 44% (4 of 9) (95% CI 18.9-73.3).

CONCLUSIONS

The addition of MBI to clinically indicated stress myocardial perfusion imaging studies in women results in a high diagnostic yield of newly detected breast cancers while generating a low rate of additional unnecessary workup.

摘要

背景

我们的目的是探讨分子乳腺成像(MBI)作为应激心肌灌注研究女性筛查技术的潜在益处。

方法

为接受 Tc-99m sestamibi 注射进行心肌灌注应激测试的女性提供 MBI。在应激同位素注射后所需的等待期内,使用专用乳腺成像伽马相机系统进行 MBI。由乳腺放射科医生解释 MBI 检查结果,并在 MBI 阳性的情况下回顾最近的乳房 X 线照片。

结果

在纳入的 322 名女性中,有 313 名完成了 MBI,其中 5 名患有已知乳腺癌,2 名患有已知高危良性乳腺病变,306 名无症状且最近的乳房 X 线照片为阴性。分析仅限于 306 名无已知乳房疾病的患者。MBI 在 306 名患者中有 22 例阳性,召回率为 7.2%(95%置信区间 [CI] 4.8-10.6)。MBI 检测到 4 例新癌症,导致额外诊断率为 13.1/1000 名筛查女性(95%CI 5.1-33.2)。每例异常 MBI 检查(PPV(1))诊断的癌症数量为 18%(22 例中的 4 例)(95%CI 7.3-38.5),每例 MBI 提示活检(PPV(3))诊断的癌症数量为 44%(9 例中的 4 例)(95%CI 18.9-73.3)。

结论

在女性有临床指征的应激心肌灌注成像研究中添加 MBI 可提高新发现乳腺癌的诊断率,同时降低额外不必要检查的发生率。

相似文献

1
Evaluation of molecular breast imaging in women undergoing myocardial perfusion imaging with Tc-99m sestamibi.评估 Tc-99m sestamibi 心肌灌注显像中接受分子乳腺成像的女性。
J Womens Health (Larchmt). 2012 Jul;21(7):730-8. doi: 10.1089/jwh.2011.3267. Epub 2012 Mar 9.
2
Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast.分子乳腺成像:一种使用锝Tc 99m乳腺闪烁造影术检测乳腺小肿瘤的新技术。
Mayo Clin Proc. 2005 Jan;80(1):24-30. doi: 10.1016/S0025-6196(11)62953-4.
3
Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.MRI、分子乳腺成像和对比增强乳腺摄影在新诊断乳腺癌女性中的诊断性能。
Radiology. 2019 Dec;293(3):531-540. doi: 10.1148/radiol.2019190887. Epub 2019 Oct 29.
4
Diagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts.乳腺钼靶致密型乳房单次补充性分子乳腺成像筛查的诊断检查及费用
AJR Am J Roentgenol. 2015 Jun;204(6):1345-53. doi: 10.2214/AJR.14.13306.
5
Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts.用于乳腺致密女性乳腺癌筛查的专用双头伽马成像。
Radiology. 2011 Jan;258(1):106-18. doi: 10.1148/radiol.10100625. Epub 2010 Nov 2.
6
Molecular Breast Imaging: A Comprehensive Review.分子乳腺成像:全面综述
Semin Ultrasound CT MR. 2018 Feb;39(1):60-69. doi: 10.1053/j.sult.2017.10.001. Epub 2017 Oct 20.
7
The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.与乳房X线摄影术相比,锝-99m甲氧基异丁基异腈闪烁乳腺造影术在评估台湾女性可触及乳腺肿块中的作用。
Anticancer Res. 2000 May-Jun;20(3B):2133-6.
8
Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer.锝-99m 马西拉肽与锝-99m 司他莫比分子乳腺成像在疑似乳腺癌患者中的比较。
EJNMMI Res. 2017 Dec;7(1):5. doi: 10.1186/s13550-017-0255-6. Epub 2017 Jan 14.
9
(99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.(99M)锝-双半胱乙酯闪烁乳腺造影术用于筛查乳腺X线摄影发现的不可触及乳腺病变。
Eur J Surg Oncol. 2007 Feb;33(1):23-7. doi: 10.1016/j.ejso.2006.10.025. Epub 2006 Nov 27.
10
Can scintimammography reduce "unnecessary" biopsies?乳腺闪烁造影术能减少“不必要的”活检吗?
Am Surg. 1998 Jul;64(7):670-2; discussion 673.

引用本文的文献

1
Direct-Conversion Molecular Breast Imaging of Invasive Breast Cancer: Imaging Features, Extent of Invasive Disease, and Comparison Between Invasive Ductal and Lobular Histology.浸润性乳腺癌的直接转换分子乳腺成像:成像特征、浸润性疾病范围以及浸润性导管癌和小叶癌组织学之间的比较
AJR Am J Roentgenol. 2015 Sep;205(3):W374-81. doi: 10.2214/AJR.14.13502.
2
Nuclear imaging of the breast: translating achievements in instrumentation into clinical use.核医学乳腺影像:将仪器研发成果转化为临床应用。
Med Phys. 2013 May;40(5):050901. doi: 10.1118/1.4802733.
3
Collimator design for a dedicated molecular breast imaging-guided biopsy system: proof-of-concept.
用于专用分子乳腺成像引导活检系统的准直器设计:概念验证。
Med Phys. 2013 Jan;40(1):012503. doi: 10.1118/1.4770274.